Pacific Biosciences of California, Inc. Stock
Equities
PACB
US69404D1081
Advanced Medical Equipment & Technology
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.94 USD | +4.86% | -11.42% | -80.22% |
Financials (USD)
Sales 2024 * | 182M | Sales 2025 * | 247M | Capitalization | 504M |
---|---|---|---|---|---|
Net income 2024 * | -248M | Net income 2025 * | -201M | EV / Sales 2024 * | 5.15 x |
Net Debt 2024 * | 434M | Net Debt 2025 * | 469M | EV / Sales 2025 * | 3.95 x |
P/E ratio 2024 * |
-1.99
x | P/E ratio 2025 * |
-2.58
x | Employees | 796 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.13% |
Latest transcript on Pacific Biosciences of California, Inc.
1 day | +5.14% | ||
1 week | -13.24% | ||
Current month | +15.15% | ||
1 month | +29.25% | ||
3 months | -62.82% | ||
6 months | -77.78% | ||
Current year | -80.63% |
Managers | Title | Age | Since |
---|---|---|---|
Stephen Turner
FOU | Founder | 56 | 00-07-13 |
Christian Henry
CEO | Chief Executive Officer | 56 | 18-07-31 |
Susan Kim
DFI | Director of Finance/CFO | 48 | 20-09-27 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Milligan
CHM | Chairman | 63 | 13-07-17 |
Marshall Mohr
BRD | Director/Board Member | 67 | 12-01-17 |
Christian Henry
CEO | Chief Executive Officer | 56 | 18-07-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
2.87% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 1.94 | +4.86% | 16 072 688 |
24-05-22 | 1.85 | +1.09% | 7,695,850 |
24-05-21 | 1.83 | -4.69% | 6,133,240 |
24-05-20 | 1.92 | -4.95% | 8,110,157 |
24-05-17 | 2.02 | -7.76% | 8,137,826 |
Delayed Quote Nasdaq, May 23, 2024 at 03:42 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-80.63% | 504M | |
+10.54% | 226B | |
+13.07% | 198B | |
+18.05% | 142B | |
+28.78% | 111B | |
+2.09% | 65.26B | |
+14.68% | 54.36B | |
+6.68% | 50.94B | |
+8.25% | 44.8B | |
+3.07% | 36.8B |
- Stock Market
- Equities
- PACB Stock